Inflammatory biomarker profiles across frailty stages in older adults
Abstract
Background: Frailty is a multidimensional syndrome associated with increased vulnerability to adverse health outcomes and has been linked to systemic and neuroinflammatory processes. Blood-based inflammatory biomarkers may help characterise biological differences across frailty stages.
Objectives: To evaluate the association between circulating inflammatory biomarkers and increasing frailty severity in older adults.
Methods: Study in 619 older adults recruited across ambulatory, hospitalised and institutionalised settings. Participants were classified as non-frail, mildly, moderately or severely frail. Plasma IL-1β, IL-6, IL-8, IL-10 and TNF-α were measured using high-sensitivity immunoassays. Given the non-normal distribution of biomarker concentrations, non-parametric analyses were performed.
Results: Valid biomarker data were available for 495–521 participants depending on the analyte. Significant differences across frailty stages were observed for all biomarkers: IL-1β, IL-6, IL-8, IL-10 and TNF-α (all p < 0.001). IL-6 showed the strongest association with frailty severity (H = 183.242), followed by TNF-α (H = 85.439) and IL-10 (H = 61.643), with higher rank distributions in frail groups compared with non-frail participants. IL-1β showed significant but more modest differences (H = 27.573). IL-8 also differed significantly across frailty stages (H = 31.108), but displayed an inverse pattern, with higher ranks in non-frail individuals. In the available post-hoc comparison between mild and advanced frailty, no biomarker remained significant after Bonferroni correction.
Conclusions: Inflammatory biomarkers differ significantly across frailty stages, supporting the existence of distinct inflammatory profiles in older adults. IL-6 and TNF-α emerge as the most strongly associated markers, suggesting that systemic inflammation may contribute to increasing frailty and multidimensional vulnerability. These biomarkers can be an indicator for the early identification of frailty.
Key messages: • Circulating inflammatory biomarkers differ significantly across frailty stages in older adults, supporting the presence of distinct biological inflammatory profiles associated with frailty severity.
• IL-6 and TNF-α showed the strongest association with increasing frailty, suggesting their potential value as early indicators of frailty and multidimensional vulnerability.
Related
- CO010 | MAPPING HEMOSTATIC BIOMARKER EXPRESSION ACROSS CANCER TYPES AND STAGES WITHIN THE HYPERCAN COHORT
- Biomarker profiles in late-life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review.
- Biomarker profiles across traditional Chinese medicine syndromes and exploratory discrimination of internal toxin syndrome in stable post-PCI patients: a cross-sectional study
- Associations of baseline levels, cumulative exposure, and two-wave patterns of the combined triglyceride-glucose index and frailty index with progression from cardiovascular-kidney-metabolic syndrome stages 0-2 to stages 3-4 and stage 4: a prospective cohort study from CHARLS.
- Multidimensional Inflammatory Biomarker Profiling in COPD: A Latent Inflammatory Construct Associated with Disease Severity and Exacerbation Burden
BibTeX
@article{fuente2026inflammatory,
title = {{Inflammatory biomarker profiles across frailty stages in older adults}},
author = {S Meijide de la Fuente and L Altuna Tellechea and R Perez Garay and MA Lazaro Naranjo and R Coya Guerrero and V Gómez Sánchez and H Martín Rodríguez and J Orcajo Lago and JE Idoyaga Uribarrena and E Arana Arri},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.851},
url = {https://doi.org/10.1093/eurpub/ckag169.851},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Inflammatory biomarker profiles across frailty stages in older adults
AU - S Meijide de la Fuente
AU - L Altuna Tellechea
AU - R Perez Garay
AU - MA Lazaro Naranjo
AU - R Coya Guerrero
AU - V Gómez Sánchez
AU - H Martín Rodríguez
AU - J Orcajo Lago
AU - JE Idoyaga Uribarrena
AU - E Arana Arri
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.851
UR - https://doi.org/10.1093/eurpub/ckag169.851
AB - Background: Frailty is a multidimensional syndrome associated with increased vulnerability to adverse health outcomes and has been linked to systemic and neuroinflammatory processes. Blood-based inflammatory biomarkers may help characterise biological differences across frailty stages. Objectives: To evaluate the association between circulating inflammatory biomarkers and increasing frailty severity in older adults. Methods: Study in 619 older adults recruited across ambulatory, hospitalised and institutionalised settings. Participants were classified as non-frail, mildly, moderately or severely frail. Plasma IL-1β, IL-6, IL-8, IL-10 and TNF-α were measured using high-sensitivity immunoassays. Given the non-normal distribution of biomarker concentrations, non-parametric analyses were performed. Results: Valid biomarker data were available for 495–521 participants depending on the analyte. Significant differences across frailty stages were observed for all biomarkers: IL-1β, IL-6, IL-8, IL-10 and TNF-α (all p < 0.001). IL-6 showed the strongest association with frailty severity (H = 183.242), followed by TNF-α (H = 85.439) and IL-10 (H = 61.643), with higher rank distributions in frail groups compared with non-frail participants. IL-1β showed significant but more modest differences (H = 27.573). IL-8 also differed significantly across frailty stages (H = 31.108), but displayed an inverse pattern, with higher ranks in non-frail individuals. In the available post-hoc comparison between mild and advanced frailty, no biomarker remained significant after Bonferroni correction. Conclusions: Inflammatory biomarkers differ significantly across frailty stages, supporting the existence of distinct inflammatory profiles in older adults. IL-6 and TNF-α emerge as the most strongly associated markers, suggesting that systemic inflammation may contribute to increasing frailty and multidimensional vulnerability. These biomarkers can be an indicator for the early identification of frailty. Key messages: • Circulating inflammatory biomarkers differ significantly across frailty stages in older adults, supporting the presence of distinct biological inflammatory profiles associated with frailty severity. • IL-6 and TNF-α showed the strongest association with increasing frailty, suggesting their potential value as early indicators of frailty and multidimensional vulnerability.
SN - 1101-1262
SN - 1464-360X
ER -